Just a reminder to all, the below link has a list of all malaria products and where they are at in their development programme.
As you can see, artimist is one of a handful of products that has reached phase III, and IMO would be the most advanced product targeting complicated malaria in children.
Whether the results are released in next month or the month after doesn't take away from the fact that we are at the pointy end as far as the trial is concerned.